Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1

Author(s): Wang GK, Russell C, Wang SY

Abstract

Mexiletine is a class 1b antiarrhythmic drug used for ventricular arrhythmias but is also found to be effective for paramyotonia congenita, potassium-aggravated myotonia, long QT-3 syndrome, and neuropathic pain. This drug elicits tonic block of Na(+) channels when cells are stimulated infrequently and produces additional use-dependent block during repetitive pulses. We examined the state-dependent block by mexiletine in human skeletal muscle hNav1.4 wild-type and inactivation-deficient mutant Na(+) channels (hNav1.4-L443C/A444W) expressed in HEK293t cells with a beta1 subunit. The 50% inhibitory concentrations (IC(50)) for the inactivated-state block and the resting-state block of wild-type Na(+) channels by mexiletine were measured as 67.8 +/- 7.0 microm and 431.2 +/- 9.4 microm, respectively (n= 5). In contrast, the IC(50) for the block of open inactivation-deficient mutant channels at +30 mV by mexiletine was 3.3 +/- 0.1 microm (n= 5), which was within the therapeutic plasma concentration range (2.8-11 microm). Estimated on- and off-rates for the open-state block by mexiletine at +30 mV were 10.4 microm(-1) s(-1) and 54.4 s(-1), respectively. Use-dependent block by mexiletine was greater in inactivation-deficient mutant channels than in wild-type channels during repetitive pulses. Furthermore, the IC(50) values for the block of persistent late hNav1.4 currents in chloramine-T-pretreated cells by mexiletine was 7.5 +/- 0.8 microm (n= 5) at +30 mV. Our results together support the hypothesis that the in vivo efficacy of mexiletine is primarily due to the open-channel block of persistent late Na(+) currents, which may arise during various pathological conditions.

Similar Articles

Sodium channelopathies of skeletal muscle result from gain or loss of function

Author(s): Jurkat-Rott K, Holzherr B, Fauler M, Lehmann-Horn F

The skeletal muscle sodium and chloride channel diseases

Author(s): Hudson AJ, Ebers GC, Bulman DE

Primary structure of the adult human skeletal muscle voltage-dependent sodium channel

Author(s): George AL Jr, Komisarof J, Kallen RG, Barchi RL

A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation

Author(s): West JW, Patton DE, Scheuer T, Wang Y, Goldin AL, et al.

Cooperative effect of S4-S5 loops in domains D3 and D4 on fast inactivation of the Na+ channel

Author(s): Popa MO, Alekov AK, Bail S, Lehmann-Horn F, Lerche H

Sodium channel mutations in paramyotoniacongenita uncouple inactivation from activation

Author(s): Chahine M, George AL Jr, Zhou M, Ji S, Sun W, et al.

Sodium channel mutations in paramyotoniacongenita exhibit similar biophysical phenotypes in vitro

Author(s): Yang N, Ji S, Zhou M, Ptácek LJ, Barchi RL, et al.

Thr1313Met mutation in skeletal muscle sodium channels in a Japanese family with paramyotoniacongenita

Author(s): Kinoshita M, Sasaki R, Nagano T, Matsuda A, Nakamura S, et al.

Voltage-gated ion channels and hereditary disease

Author(s): Lehmann-Horn F, Jurkat-Rott K